Virginia Retirement Systems Et Al Vanda Pharmaceuticals Inc. Transaction History

Virginia Retirement Systems Et Al

$10.1 Billion
Q3 2023

A detailed history of Virginia Retirement Systems Et Al transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 248,300 shares of VNDA stock, worth $1.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

248,300

Previous 52,400 373.85%

Holding current value

$1.19 Million

Previous $345,000 210.72%

% of portfolio

0.01%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jan 02, 2024	BUY	$4.28 - $6.57 $838,452 - $1.29 Million	195,900 Added 373.85%	248,300 $1.07 Million
Q2 2023 Aug 22, 2023	BUY	$5.9 - $6.95 $11,210 - $13,205	1,900 Added 3.76%	52,400 $345,000
Q1 2023 Jul 11, 2023	BUY	$6.18 - $7.99 $72,924 - $94,282	11,800 Added 30.49%	50,500 $342,000
Q4 2022 May 17, 2023	BUY	$6.87 - $10.96 $21,984 - $35,072	3,200 Added 9.01%	38,700 $286 Million
Q3 2022 May 16, 2023	BUY	$9.44 - $11.76 $123,664 - $154,056	13,100 Added 58.48%	35,500 $351 Million
Q1 2022 Apr 21, 2022	SELL	$10.84 - $16.55 $61,788 - $94,335	-5,700 Reduced 20.28%	22,400 $253,000
Q4 2021 Feb 03, 2022	SELL	$15.69 - $21.14 $152,193 - $205,058	-9,700 Reduced 25.66%	28,100 $441,000
Q3 2021 Oct 21, 2021	SELL	$15.35 - $21.27 $174,990 - $242,478	-11,400 Reduced 23.17%	37,800 $648,000
Q2 2021 Aug 13, 2021	SELL	$15.71 - $21.51 $12,568 - $17,208	-800 Reduced 1.6%	49,200 $1.06 Million
Q1 2021 Apr 30, 2021	SELL	$13.42 - $20.28 $55,022 - $83,148	-4,100 Reduced 7.58%	50,000 $751,000
Q4 2020 Feb 16, 2021	BUY	$9.77 - $13.81 $265,744 - $375,632	27,200 Added 101.12%	54,100 $711,000
Q3 2020 Nov 12, 2020	BUY	$9.32 - $12.02 $250,708 - $323,338	26,900 New	26,900 $260,000
Q1 2019 Apr 25, 2019	SELL	$17.59 - $31.05 $1.16 Million - $2.05 Million	-66,000 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$18.97 - $31.47 $533,057 - $884,307	28,100 Added 74.14%	66,000 $1.73 Million
Q3 2018 Nov 02, 2018	SELL	$18.25 - $23.0 $31,025 - $39,100	-1,700 Reduced 4.29%	37,900 $870,000
Q2 2018 Aug 03, 2018	BUY	$13.95 - $19.15 $552,420 - $758,340	39,600 New	39,600 $754,000

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $270M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Vanda Pharmaceuticals Inc. Transaction History